• Ph.D. in Pharmacoepidemiology with 9+ years of industry real-world evidence (RWE) experience across more than 20 US and global RWDs, including claims, EHR/EMR, hospital administration, registry, survey, health and productivity, data linkage, etc.• Extensive RWE strategy and research experience, identifying unmet needs and using observational research methods to define appropriate research questions and data sources, study design, rigorous and fit-for-purpose analytical approaches, with 19 publications in peer-reviewed journals.• Led/supported high-profile RWE studies successfully, including label expansion, integrating RWE into clinical trials, RWE generation for regulatory submissions, HTA submissions, reimbursement coverage submissions, value-based healthcare, acquisition decisions, and other important strategy decisions.